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Introduction-objectives: Carotid artery stenting (CAS) process, especially in high-
risk patients, is carotid endarterectomy (CEA) alternative. Our aim in this study, the
reliability of CAS process, to evaluate the clinical and radiological results of the
second year.
Method: 120 patients [mean age 68 (48-86)] who have admitted to our hospital
between December 2010 and March 2013 and CAS decision taken, were included in
the study. Patients with symptomatic carotid artery and 50% of those with stenosis,
patients with asymptomatic carotid artery stenosis greater than 70% were included.
80% of asymptomatic patients, coronary bypass surgery in patients who had pre-
created screen-detected. 75% of symptomatic patients, 81% of coronary artery disease,
64% of hypertensive, was 44% of the diabetic. 81% of male patients in our study
group, the rate of smoking was 40%. Patients were on average 21 months (2-28
months), were followed. All the patients before the procedure, carotid doppler ultra-
sound and patients who require computed tomography (CT) angiography, was per-
formed. Ultrasound, instent peak ﬂow velocity 224 cm/sec and CT angiography in
the detection of stenosis 50% was considered as restenosis. CAS operation, 62% of
patients, proximal-lock braking system (Mo.Ma), 38% in the distal embolic
protection device (Anjioguard) was used. 23% of patients (28 patients) had bilateral
carotid artery stenosis. Of these patients, 19 of them lock braking system proximal,
distal embolic protection device was used in 9 of them. 9 patients (7%) 100% against
the carotid artery was occluded. Distal embolic protection devices were used in these
patients.
Results: One patient (0.8%) 24 hours after treatment, cerebrovascular ischemic events
with sequelae, developed. Patients were followed up for neurology and medical
recommendation. 2 patients (1.7%), 6 and 11 months after treatment of transient
ischemic attack (TIA) is observed. TIA patients undergoing open carotid stents was
observed, in one of these patients with paroxysmal atrial ﬁbrillation was detected and
warfarin medication was started, other patients cranial angiography, intracerebral
lesions in the arteries viewed and neurology clinic with the proposal of a serious
medical follow-up was continued. 3 (2.5%) patients were asymptomatic, 12th month
restenosis were detected with doppler ultrasound scans and conﬁrmed by CT angi-
ography. Two of the patients with restenosis, one of them %60 stent restenosis in
carotid artery, while the other was at the level of 80%. For patient who has 80%
stenosis lesion, CEA procedures were performed. Symptomatic restenosis was not
observed.
Conclusıon: CAS-treated patients in our clinic, the success and complication rates are
similar to other studies.The largest share of low complication and high success rates,
getting experience in our clinic, patient selection and follow-up with neurology and
radiology clinics provide an important contribution are made in the opinion.
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Backgroun and Aim: Atrial ﬁbrillation (AF) is the most common arrhythmia
observed in severe aortic stenosis (AS) and important prognostic indicator for clinicalJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTdeterioration. The difference between maximum and minimum p wave duration
deﬁned as p-wave dispersion (PWD), reﬂecting heterogeneous atrial conduction has
been proposed as being useful for the estimation of AF. The aim of this study was to
evaluate PWD in patients after decreasing left atrium pressure load following trans-
catheter aortic valve implantation (TAVI).
Methods: 60 consecutive patients from 68 to 96 (77,6) years old with severe AS were
enrolled the study. Maximum, minimum P wave duration and PWD were calculated
from 12-lead surface electrocardiograms (ECG) at a rate of 50mm/s before and after
the TAVI. The measurements of the P-wave duration were performed manually by
two of the investigators. To improve accuracy, measurements were performed with
calipers and magnifying lens for deﬁning the ECG deﬂection. P-wave duration was
measurements from the onset to the offset of the P wave. All patients were assessed by
echocardiography to measure left atrium diameter, left ventricle ejection fraction,
max-mean aortic gradient, aortic valve velocity, aort valve area.
Results: All patients had severe AS (max/mean gradients: 85,2/52,8 mmHg, Aortic
valve area: 0.6 cm2, mean left atrium diameter:5.21.2 cm) and high surgical risk
(logistic euroscore: %21,7, STS: 7,7). PWD was correlated with LA diameter and
mean aortic gradient. There was statistically signiﬁcant difference before and after
TAVI in PWD (p<0.001). Patients’ PWD after TAVI (40,723,6; p:0.012) and and
1st week after TAVI (33,222,8; p<0.001) was signiﬁcantly lower than before the
TAVI (46.027.8). Also statistically signiﬁcant difference of PWD was observed
between after TAVI and 1st week after TAVI (p.0.004). AF was seen in six patients
after TAVI. In addition, after TAVI, patients with AF had signiﬁcantly higher PWD
than those without AF (p<0.001).
Conclusıon: PWD was found to be signiﬁcantly higher in AS due to pressure over-
load. After TAVI, decreasing atrial pressure can be changes atrial repolarization and
reduce the risk of AF. PWD could be useful predictor for the development of AF after
TAVI.ERS C233
